Hims & Hers Health, Inc.
HIMS · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $12,838 | $11,185 | $6,560 | $5,296 |
| - Cash | $346 | $1,125 | $274 | $221 |
| + Debt | $1,118 | $1,044 | $63 | $11 |
| Enterprise Value | $13,611 | $11,105 | $6,349 | $5,087 |
| Revenue | $599 | $545 | $586 | $481 |
| % Growth | 9.9% | -7% | 21.8% | – |
| Gross Profit | $442 | $416 | $431 | $370 |
| % Margin | 73.8% | 76.4% | 73.5% | 76.8% |
| EBITDA | $30 | $37 | $66 | $25 |
| % Margin | 5% | 6.8% | 11.3% | 5.1% |
| Net Income | $16 | $43 | $49 | $26 |
| % Margin | 2.6% | 7.8% | 8.4% | 5.4% |
| EPS Diluted | 0.06 | 0.17 | 0.2 | 0.11 |
| % Growth | -64.7% | -15% | 81.8% | – |
| Operating Cash Flow | $149 | -$19 | $109 | $86 |
| Capital Expenditures | -$57 | -$50 | -$59 | -$27 |
| Free Cash Flow | $91 | -$69 | $50 | $60 |